Search Results - "Czul, Frank"

Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease by Kalyan Ram, Bhamidimarri, Frank, Czul, Adam, Peyton, Cynthia, Levy, Maria, Hernandez, Lennox, Jeffers, David, Roth, Eugene, Schiff, Christopher, O’Brien, Paul, Martin

Get full text

Novel Therapies on Primary Biliary Cirrhosis by Czul, Frank, MD, Levy, Cynthia, MD

“…All patients with primary biliary cirrhosis (PBC) and abnormal liver biochemistry should be considered for specific therapy. Ursodeoxycholic acid (UDCA) is the…”
Get full text

Continuous-flow left ventricular assist devices as a cause of acquired von Willebrand syndrome and GI bleeding by Czul, Frank, MD, Barkin, Jamie S., MD

Get full text

Continuous-flow Left Ventricular Assist Device, Valvular Disease, and Acquired von Willebrand Syndrome by Czul, Frank, MD, Barkin, Jamie S., MD

Get full text

Primary Biliary Cirrhosis by Czul, Frank, MD, Peyton, Adam, DO, Levy, Cynthia, MD

“…Primary biliary cirrhosis (PBC) is a chronic and slowly progressive cholestatic liver disease characterized by destruction of the interlobular bile ducts,…”
Get full text

Propylthiouracil-Induced Acute Liver Failure: Role of Liver Transplantation by Carrion, Andres F., Czul, Frank, Arosemena, Leopoldo R., Selvaggi, Gennaro, Garcia-Buitrago, Monica T., Tekin, Akin, Tzakis, Andreas G., Martin, Paul, Ghanta, Ravi K.

“…Propylthiouracil- (PTU-) induced hepatotoxicity is rare but potentially lethal with a spectrum of liver injury ranging from asymptomatic elevation of…”
Get full text

Persistent Enteritis as the Defining Manifestation of Lupus: 2723 by Torrealba, Mauricio, Czul, Frank, Berzosa, Manuel

Get full text

Hepatobiliary manifestations of inflammatory bowel disease by Yarur, Andres J, Czul, Frank, Levy, Cynthia

“…Patients with inflammatory bowel diseases (IBDs) may present with several hepatic abnormalities. Some of these liver diseases are benign and only require…”
Get full text

Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy by Yarur, Andres J, Kubiliun, Maddie J, Czul, Frank, Sussman, Daniel A, Quintero, Maria A, Jain, Anjali, Drake, Katherine A, Hauenstein, Scott I, Lockton, Steven, Deshpande, Amar R, Barkin, Jamie S, Singh, Sharat, Abreu, Maria T

“…Background & Aims In patients with inflammatory bowel diseases, the combination of infliximab and thiopurines (such as 6-thioguanine) is more effective…”
Get full text

Noninvasive Markers to Assess Liver Fibrosis by Czul, Frank, Bhamidimarri, Kalyan R

“…Chronic liver disease represents a major public health problem, accounting for significant morbidity and mortality worldwide. Their prognosis and management…”
Get full text

Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease by Yarur, Andres J, Quintero, Maria A, Jain, Anjali, Czul, Frank, Barkin, Jamie S, Abreu, Maria T

“…Serum amyloid A (SAA) is an acute-phase protein, but its role as a biomarker of disease activity in Crohn's disease is unclear. The aim of the study was to…”
Get full text

Primary biliary cirrhosis: therapeutic advances by Czul, Frank, Peyton, Adam, Levy, Cynthia

“…Primary biliary cirrhosis (PBC) is a chronic and slowly progressive cholestatic liver disease characterized by destruction of the interlobular bile ducts,…”
Get full text

Serum Vitamin B12 Level Could Be a Novel Diagnostic Marker to Predict Cirrhosis in Patients With Chronic Liver Disease: 641 by Czul, Frank, Yarur, Andres, Bhamidimarri, Kalyan

Get full text

388 HIGHER VISCERAL ADIPOSE TISSUE IS ASSOCIATED WITH LOWER RATES OF STEROID-FREE DEEP AND ENDOSCOPIC REMISSION IN PATIENTS STARTING BIOLOGIC THERAPY FOR INFLAMMATORY BOWEL DISEASES: RESULTS FROM THE CONSTELLATION STUDY by Yarur, Andres J., Bruss, Alexandra, Nunez, Lizbeth, Moosreiner, Andrea, Stein, Daniel J., Agrawal, Dilpesh, Czul, Frank, Thorgerson, Abigail, Deepak, Parakkal, Beniwal-Patel, Poonam

Get full text

A Small Bowel With Too Many Exits: An Astonishing Surgical Finding in a Patient With Crohn's Disease by Czul, Frank, Beduschi, Thiago, Deshpande, Amar R

Get full text

Image of the Month: A Small Bowel With Too Many Exits: An Astonishing Surgical Finding in a Patient With Crohn's Disease by Czul, Frank, Beduschi, Thiago, Deshpande, Amar R

Get full text

Fr539 COMBINED EFFECT OF PENTOXIFYLLINE WITH VEDOLIZUMAB IN THE MANAGEMENT OF PATIENTS WITH CROHN'S DISEASE by Berera, Shivali, Ioannou, Stephanie, Mantero, Alejandro, Morillo, Diana, Pignac-Kobinger, Judith, Colina, Niurka, Rodriguez, Jennifer, Abreu, Maria T., Sussman, Daniel, Kerman, David H., Damas, Oriana, Santander, Ana M., Czul, Frank, Deshpande, Amar R.

Get full text

Inflammatory Cytokine Profile in Crohn’s Disease Non-Responders to Optimal Anti-Tumor Necrosis Factor Therapy by Yarur, Andres J., Jain, Anjali, Quintero, Maria A, Czul, Frank, Deshpande, Amar R., Kerman, David H., Abreu, Maria T.

Get full text

Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems by Sclair, Seth N., Carrasquillo, Olveen, Czul, Frank, Trivella, Juan P., Li, Hua, Jeffers, Lennox, Martin, Paul

“…Background Evidence-based guidelines and quality indicators for cirrhosis care have been established. Whether there are variations in adherence to these…”
Get full text

Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease by Saad, Abdo M, Czul, Frank, Sakuraba, Atsushi, Rubin, David T, Cohen, Russell D

“…Although Crohn's disease (CD) is usually diagnosed at a younger age, a growing population of patients with inflammatory bowel disease is diagnosed above age 60…”
Get full text